Transforming growth factor-β1 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway

Molecular Medicine

Volumn 20, Issue 1, 2014, Pages 120-134

  Cui, Ye ^a   Osorio, Juan C ^a   Risquez, Cristobal ^a   Wang, Hao ^a   Shi, Ying ^a   Gochuico, Bernadette R ^b   Morse, Danielle ^a   Rosas, Ivan O ^a   El Chemaly, Souheil ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUBERIN; VASCULOTROPIN D; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; FETUS; FIBROSING ALVEOLITIS; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG FIBROBLAST; LUNG HOMOGENATE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL CULTURE; CELL LINE; CYTOLOGY; FIBROBLAST; GENETICS; LUNG; METABOLISM;

CELL LINE; CELLS, CULTURED; DOWN-REGULATION; FIBROBLASTS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 84897839879     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2013.00123     Document Type: Article

References (61)

1. Adams RH, Alitalo K. (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8:464-78.
2. Man XY, Yang XH, Cai SQ, Yao YG, Zheng M. (2006) Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol. Med. 12:127-36.
3. Yamazaki Y, Morita T. (2006) Molecular and functional diversity of vascular endothelial growth factors. Mol. Divers. 10:515-27.
4. Jia H, et al. (2004) Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells. J. Biol. Chem. 279:36148-57.
5. Ferrara N, Gerber HP, LeCouter J. (2003) The biology of VEGF and its receptors. Nat. Med. 9:669-76.
6. Achen MG, et al. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. U. S. A. 95:548-53.
7. Stacker SA, et al. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7:186-91.
8. McColl BK, et al. (2007) Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J. 21:1088-98.
9. McColl BK, et al. (2003) Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J. Exp. Med. 198:863-8.
10. Stacker SA, et al. (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J. Biol. Chem. 274:32127-36.
11. Yamada Y, Nezu J, Shimane M, Hirata Y. (1997) Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 42:483-8.
12. Karkkainen MJ, et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5:74-80.
13. Baldwin ME, et al. (2005) Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol. Cell. Biol. 25:2441-9.
14. Koch M, et al. (2009) VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis. J. Path. 219:356-64.
15. Paquet-Fifield S, et al. (2013) Vascular endothelial growth factor-d modulates caliber and function of initial lymphatics in the dermis. J. Invest. Dermatol. 133:2074-84.
16. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. (1996) Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/ vascular endothelial growth factor family. Proc. Natl. Acad. Sci. U. S. A. 93:11675-80.
17. Debinski W, et al. (2001) VEGF-D is an X-linked/ AP-1 regulated putative onco-angiogen in human glioblastoma multiforme. Mol. Med. 7:598-608.
18. Orlandini M, Oliviero S. (2001) In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. J. Biol. Chem. 276:6576-81.
19. Mountain DJ, Singh M, Singh K. (2008) Downregulation of VEGF-D expression by interleukin-1beta in cardiac microvascular endothelial cells is mediated by MAPKs and PKCalpha/beta1. J. Cell. Physiol. 215:337-43.
20. Oc P, Rhys-Evans P, Modjtahedi H, Eccles SA. (2000) Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells. Clin. Exp. Metastasis. 18:155-61.
21. Orlandini M, Semboloni S, Oliviero S. (2003) Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability. J. Biol. Chem. 278:44650-6.
22. Glasgow CG, Avila NA, Lin JP, Stylianou MP, Moss J. (2009) Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement. Chest. 135:1293-300.
23. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. (2002) Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer. 2:573-83.
24. Achen MG, Stacker SA. (2012) Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance. Growth Factors. 30:283-96.
25. Selman M, Pardo A, Kaminski N. (2008) Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med. 5:e62.
26. Ju W, et al. (2012) Inhibition of alpha-SMA by the ectodomain of FGFR2c attenuates lung fibrosis. Mol. Med. 18:992-1002.
27. Gross TJ, Hunninghake GW. (2001) Idiopathic pulmonary fibrosis. N. Engl. J. Med. 345:517-25.
28. Kobayashi T, et al. (2005) Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts. Biochem. Biophys. Res. Commun. 327:393-8.
29. Suzuki Y, et al. (2012) Transforming growth factor-beta induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney Int. 81:865-79.
30. Raghu G, et al. (2011) An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183:788-824.
31. Yuan B, Latek R, Hossbach M, Tuschl T, Lewitter F. (2004) siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 32:W130-4.
32. Schmittgen TD, Livak KJ. (2008) Analyzing realtime PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-8.
33. Bonniaud P, et al. (2005) Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am. J. Respir. Crit. Care Med. 171:889-98.
34. Derynck R, Zhang YE. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 425:577-84.
35. Bauge C, Cauvard O, Leclercq S, Galera P, Boumediene K. (2011) Modulation of transforming growth factor beta signalling pathway genes by transforming growth factor beta in human osteoarthritic chondrocytes: involvement of Sp1 in both early and late response cells to transforming growth factor beta. Arthritis Res. Ther. 13:R23.
36. Poncelet AC, Schnaper HW, Tan R, Liu Y, Runyan CE. (2007) Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation. J. Biol. Chem. 282:15534-40.
37. Zhang YE. (2009) Non-Smad pathways in TGFbeta signaling. Cell Res. 19:128-39.
38. Jordana M, et al. (1988) Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am. Rev. Respir. Dis. 137:579-84.
39. Raghu G, Chen YY, Rusch V, Rabinovitch PS. (1988) Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am. Rev. Respir. Dis. 138:703-8.
40. Miki H, et al. (2000) Fibroblast contractility: usual interstitial pneumonia and nonspecific interstitial pneumonia. Am. J. Respir. Crit. Care Med. 162:2259-64.
41. Shoda H, et al. (2007) Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis. Biochem. Biophys. Res. Commun. 353:1004-10.
42. Chen M, et al. (2012) Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS One. 7:e28203.
43. Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. (2012) TGF-beta-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J. Cell Sci. 125:1259-73.
44. Carsillo T, Astrinidis A, Henske EP. (2000) Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc. Natl. Acad. Sci. U. S. A. 97:6085-6090.
45. Hanrahan V, et al. (2003) The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenomacarcinoma sequence during colorectal cancer progression. J. Pathol. 200:183-94.
46. George ML, et al. (2001) VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia. 3:420-7.
47. Leask A, Abraham DJ. (2004) TGF-beta signaling and the fibrotic response. FASEB J. 18:816-27.
48. Shin EH, Basson MA, Robinson ML, McAvoy JW, Lovicu FJ. (2012) Sprouty is a negative regulator of transforming growth factor beta-induced epithelial-to-mesenchymal transition and cataract. Mol. Med. 18:861-73.
49. Itoh S, et al. (2003) Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J. Biol. Chem. 278:3751-61.
50. Yamashita M, et al. (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol. Cell. 31:918-24.
51. Shi-Wen X, et al. (2006) Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors. Mol. Cell. Biol. 26:5518-27.
52. Wygrecka M, et al. (2012) TGF-beta1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner. Am. J. Respir. Cell Mol. Biol. 47:614-27.
53. Petrich BG, et al. (2002) c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ. Res. 91:640-7.
54. Glaser ND, Lukyanenko YO, Wang Y, Wilson GM, Rogers TB. (2006) JNK activation decreases PP2A regulatory subunit B56alpha expression and mRNA stability and increases AUF1 expression in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 291:H1183-92.
55. Zucconi BE, Wilson GM. (2013) Assembly of functional ribonucleoprotein complexes by AUrich element RNA-binding protein 1 (AUF1) requires base-dependent and-independent RNA contacts. J. Biol. Chem. 288:28034-48.
56. Liu YH, et al. (2008) Up-regulation of vascular endothelial growth factor-D expression in clear cell renal cell carcinoma by CD74: a critical role in cancer cell tumorigenesis. J. Immunol. 181:6584-94.
57. Majumder M, et al. (2012) Co-expression of alpha9beta1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN. PLoS One. 7:e35094.
58. Young LR, et al. (2013) Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet Respir. Med. 1:445-52.
59. Wynn TA. (2011) Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208:1339-50.
60. El-Chemaly S, et al. (2009) Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms. Proc. Natl. Acad. Sci. U. S. A. 106:3958-63.
61. Lara AR, et al. (2012) Increased lymphatic vessel length is associated with the fibroblast reticulum and disease severity in usual interstitial pneumonia and nonspecific interstitial pneumonia. Chest. 142:1569-76.